ACC's CardioSmart is holding a challenge to educate Fellows in Training (FITs) about the importance of shared decision-making. An essential component of the patient-clinician relationship, shared ...

ACC Online Courses offer the cardiovascular community a collection of resources and newly developed, evidence-based educational activities across topics such as lipid management, valvular heart ...

The ACC Young Scholars Program is designed for high school and undergraduate students who are interested in a career in cardiology, science, or health care. Our goal is to provide an opportunity for ...

A novel artificial intelligence (AI) model applied to a 12-lead electrocardiogram (ECG) image was able to identify individuals at elevated risk of heart failure (HF) across multinational cohorts ...

The U.S. Food and Drug Administration (FDA) announced on Jan. 13 that Philips is correcting the Monitoring Service Application used with Mobile Cardiac Telemetry Monitoring as some electrocardiogram ...

ACC's EP Device Implant Registry is a critical tool for tracking and improving outcomes for patients receiving ICD/CRT-D and pacemaker procedures. The newly launched Version 3.0 has streamlined ...

The SUMMIT trial compared the safety and efficacy of tirzepatide among patients with heart failure with preserved ejection fraction (HFpEF) and obesity. Results from the trial concluded that treatment ...

A polypill for cardiovascular disease may be cost saving and a high value treatment in a low-income, majority Black population with limited health care access at a price point of $463, according to ...

"Wildfires, compound extreme events, climate change and cardiovascular health," are the central theme of an editorial authored by Kai Chen, PhD; Yuan Lu, ScD, and Harlan M. Krumholz, MD, SM, FACC; in ...

Personalized heart digital twin models accurately detect substrate and functional abnormalities during ablation for scar-dependent ventricular tachycardia (VT), according to findings from a ...

Overweight and obesity are common in patients with heterozygous familial hypercholesterolemia (HeFH) and are associated with a greater risk of atherosclerotic cardiovascular disease (ASCVD) starting ...

The utility of left atrial appendage occlusion (LAAO) as a therapy for stroke prevention in patients with nonvalvular atrial fibrillation (AFib) is the focus of a State-of-the-Art Review published Jan ...